What CDL Nuclear Technologies does

CDL Nuclear Technologies, founded in 1992 and headquartered in Cranberry Township, Pennsylvania, is a private US provider of end-to-end cardiac PET/CT and SPECT myocardial perfusion imaging solutions. The company sells to independent cardiology practices, hospital cardiology departments, health systems, and IDTFs, and reports operational relationships across 139 sites in 28 states. It is described as the leading provider of affordable Cardiac PET MPI in the US, supporting 1 in 3 US cardiac PET patients, and as the world's largest purchaser of Rubidium-82 generators. The CEO, Lon Wilson, also leads the Cardiac PET Industry Coalition and holds multiple US patents in diagnostic medical devices that underpin the CardioNavix on-demand mobile Rubidium service.

The product portfolio is built around four interconnected service lines: (1) Custom Cardiac PET/CT Suite Solutions — turnkey suite buildouts delivered in approximately 180 days via an exclusive 200-point process covering construction, equipment, training, accreditation, billing, and maintenance; (2) CardioNavix Daily Use Mobile Rubidium — America's only on-demand mobile Rubidium-82 generator delivery service for facilities with existing PET/CT equipment; (3) Mobile Cardiac PET/CT Trailer services — fully staffed and PACS-integrated mobile imaging units with fixed-site options; and (4) SPECT Solutions — fixed and mobile SPECT, UltraSPECT Xpress3 time/dose reduction software, and nationwide radiopharmaceutical distribution (Sestamibi, Myoview, Thallium, Lexiscan, Adenosine, Persantine). Equipment is sourced from Siemens Healthineers, GE HealthCare, Philips, Digirad, and IS2, with ScImage providing reading-station software.

The business model is a managed services / equipment leasing hybrid priced under multi-year contracts with little to no upfront cost to the customer. CDL targets cardiology decision-makers through an enterprise field sales motion supported by industry events (ASNC, AHRA, RSNA, MedAxiom), webinars, and co-marketing with equipment OEMs. Named reference customers include Houston Cardiovascular Associates and Hackensack Radiology Group. CDL operates a wholly owned subsidiary, CardioNavix, which delivers the on-demand mobile Rubidium service, and has a C-suite built out between 2022 and 2023 across finance, commercial, operations, and compliance functions. The company is privately held with no disclosed funding rounds or parent company.

Name

CDL Nuclear Technologies

Legal name

CDL Nuclear Technologies

Website

https://cdlnuclear.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Short description

CDL Nuclear Technologies provides end-to-end cardiac PET/CT and SPECT imaging solutions to independent cardiology practices and hospitals across 28 US states. The company offers turnkey suite buildouts, CardioNavix on-demand mobile Rubidium-82 delivery, mobile PET/CT trailers, and managed SPECT services on multi-year contracts.

Ownership category

akta.pro rank

Product category

Cardiac PET and SPECT Imaging Services

NAICS

Irradiation Apparatus Manufacturing (334517)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)

akta.pro primary industry

Radiopharmaceutical CDMO & Manufacturing (GMP Fill-Finish) (HLAIAGAF)

akta.pro secondary industry

Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC) (EUAKAIAC)

Keywords

• Cardiac PET imaging
• SPECT nuclear cardiology
• Rubidium-82 delivery
• Mobile imaging services
• Radiopharmaceutical distribution

Headquarters

HQ city

Cranberry Twp

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Custom Cardiac PET/CT Suite Solutions: CDL provides complete, customized PET and PET/CT suites with little to no upfront costs to cardiology practices and hospitals. Revenue is generated through equipment leasing, service agreements, and ongoing operational support including staffing, isotopes, maintenance, and supply delivery.
2. Mobile Rubidium Delivery Services: CDL CardioNavix delivers portable Rubidium-82 generators and accompanying nuclear services on-demand to healthcare facilities. This enables practices to offer Cardiac PET without purchasing equipment outright. Revenue is generated per delivery/service event, with practices paying for the isotope delivery and associated services.
3. Mobile Cardiac PET/CT Trailer Services: CDL offers mobile cardiac PET/CT trailers that can be placed at facilities. The company provides staffing (nuclear tech and stress tech), equipment, and operational support. Revenue comes from trailer service agreements, staffing fees, and per-scan operational support.
4. SPECT Solutions: CDL provides SPECT equipment delivery, installation, and operation services along with radiopharmaceutical distribution (generic Sestamibi, Myoview, Thallium, Lexiscan, Adenosine, Persantine) at competitive prices through nationwide partnership agreements. Additional services include equipment maintenance, monitoring badge services, professional staffing, and medical physics services.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

CDL Nuclear Technologies is a managed-services provider that enables cardiology practices and hospitals to offer Cardiac PET/CT and SPECT myocardial perfusion imaging without large capital outlays. Its core offering is an end-to-end imaging program delivered through custom suite buildouts, on-demand mobile Rubidium-82 isotope delivery (CardioNavix), mobile PET/CT trailers, and SPECT equipment, all bundled with staffing, training, accreditation, billing, and maintenance support.

Product overview

CDL Nuclear Technologies is an end-to-end Cardiac PET and PET/CT solutions provider offering a portfolio of four interconnected service lines: Custom Cardiac PET/CT Suite Solutions (customized turnkey suite buildouts with no upfront costs, implemented in ~180 days), Daily Use Mobile Rubidium for Cardiac PET Solutions (CardioNavix on-demand Rubidium-82 generator delivery), Mobile Cardiac PET/CT Solutions (mobile and fixed trailer services with state-of-the-art PET/CT scanners), and SPECT Solutions (fixed site and mobile SPECT with radiopharmaceutical distribution, equipment service, staffing, and medical physics support). The company serves independent cardiology practices and hospitals across the US, providing comprehensive imaging solutions that include equipment, isotopes, staffing, training, accreditation, and billing support.

Differentiator

Problem solved

Functional benefit

Brands

• CardioNavix: America's only provider of on-demand Rubidium isotope for Cardiac PET, providing mobile delivery of Rubidium-82 generators to healthcare facilities
• CDL CardioNavix
• Cardiac PET 360

Products and services

• Custom Cardiac PET/CT Suite Solutions End-to-end custom Cardiac PET/CT suite buildouts for independent cardiology practices and hospitals, including suite planning, construction, equipment acquisition, physician/staff training, accreditation support, customized patient resources, billing assistance, risk management, and maintenance. Delivered with little to no upfront cost.
• Daily Use Mobile Rubidium for Cardiac PET Solutions (CardioNavix) On-demand mobile Rubidium-82 generator service (CardioNavix brand) that delivers a portable generator to hospitals, health systems, clinics, and IDTFs, allowing them to use existing PET or PET/CT equipment for Cardiac PET imaging without purchasing their own generator. CDL delivers the Rb-82 infusion system before the clinic opens and removes it after the clinic closes.
• Mobile Cardiac PET/CT Solutions Mobile Cardiac PET/CT trailer services providing fixed and mobile PET/CT imaging capabilities. Includes CDL radioactive material license with RSO & Physicist, trailer staffing (Nuclear Tech and Stress Tech), state-of-the-art PET/CT system with gated perfusion imaging and myocardial blood flow evaluation, IT integration with PACS, and billing consultation.
• SPECT Solutions Comprehensive SPECT solutions including fixed site suites, mobile SPECT, and radiopharmaceutical distribution (Sestamibi, Myoview, Thallium, Lexiscan, Adenosine, Persantine). Bundles UltraSPECT Xpress3 time/dose reduction software, equipment maintenance, monitoring badge services, professional staffing, and medical physics services.

Quantifiable outcome

• PET MPI has 86% sensitivity and 100% specificity compared to SPECT's 81% sensitivity and 66% specificity for detecting 50% coronary stenosis
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and supporting.

• Houston Cardiovascular AssociatescoreStrategic or Co-development Partner · 5 September 2025Houston Cardiovascular Associates partnered with CDL Nuclear Technologies to improve diagnostic accuracy and workflow efficiency in cardiac care, utilizing advanced PET/CT scanners and radiopharmaceutical delivery systems. CDL provided its mobile and leasing solutions to enable the practice to offer Cardiac PET/CT imaging services, reducing unnecessary procedures and improving patient outcomes.
• Siemens HealthineerscoreTechnology or IntegrationCDL Nuclear Technologies partners with Siemens Healthineers for Cardiac PET/CT equipment. CDL's custom suites feature Siemens cameras (e.g., Siemens Horizon camera), and the companies co-market cardiac PET/CT imaging solutions. Siemens Healthineers publishes content highlighting CDL's efforts in expanding cardiac PET access through leasing models and mobile units.
• GE HealthCarecoreTechnology or IntegrationCDL Nuclear Technologies works with GE HealthCare for Cardiac PET/CT equipment. CDL's custom suites include GE cameras (e.g., GE Omni camera). CDL is also positioned alongside GE HealthCare in the cardiac PET imaging market, with both companies collaborating in content that highlights the growth of cardiac PET/CT imaging.
• Philips HealthcaresupportingTechnology or IntegrationCDL Nuclear Technologies provides delivery, installation, and operation of SPECT equipment from Philips as part of its SPECT solutions. CDL has nationwide partnership agreements with favorable pricing on radioisotopes and equipment from premier manufacturers including Philips.
• UltraSPECTsupportingTechnology or IntegrationCDL Nuclear Technologies offers the UltraSPECT Xpress3 product line for time and dose reduction in SPECT imaging. The Xpress3 allows half-dose and half-time imaging protocols and meets 2014 ASNC dose reduction guidelines. CDL integrates this technology into its SPECT solutions offering.
• ScImagesupportingTechnology or IntegrationCDL Nuclear Technologies' mobile cardiac PET/CT trailers include reading stations powered by ScImage with Cedars or 4 DM software for image interpretation and reporting. This technology partnership enables CDL to provide complete imaging solutions including picture archiving and communication system (PACS) integration.
• CardioNavixcoreStrategic or Co-development PartnerCardioNavix is a subsidiary of CDL Nuclear Technologies (also co-owned by CEO Lon Wilson) that provides on-demand mobile Rubidium-82 generators for cardiac PET imaging. CardioNavix is America's only provider of on-demand Rubidium isotope for Cardiac PET and is a core component of CDL's service offerings.
• MedAxiomsupportingGTM or Marketing PartnerCDL Nuclear Technologies co-hosts webinars with MedAxiom, a cardiovascular healthcare solutions organization. These webinars focus on clinical advantages of Cardiac PET imaging, cost-saving benefits, and practical implementation considerations. MedAxiom serves as a platform for CDL to reach cardiovascular leaders and clinician decision-makers.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Philips Healthcare: OEM of SPECT and PET imaging equipment used by CDL's SPECT Solutions line. Like Siemens and GE, Philips is a broad incumbent in cardiac imaging that could bundle equipment with services to compete with CDL's managed model.
• GE HealthCare: Major PET/CT and SPECT OEM supplying scanners such as the GE Omni into CDL's custom suites and co-marketing cardiac PET content. As a broad incumbent, GE HealthCare could expand into managed cardiac PET services that overlap with CDL's offering.
• Siemens Healthineers: Global OEM of PET/CT and SPECT scanners used in CDL's custom suites (e.g., Siemens Horizon). It is a core technology partner but also a broad incumbent that could compete with CDL by deepening direct services around its own cardiac PET equipment.

Direct peers

• Digirad: Provider of nuclear imaging equipment and mobile imaging services with historical exposure to cardiac SPECT. As a direct peer in mobile/managed nuclear cardiology services, Digirad competes for the same independent practice customer segment as CDL.
• Bracco Imaging: Manufacturer of Rubidium-82 generators that supply CDL's CardioNavix mobile isotope service. While currently a supplier, Bracco's control of Rb-82 production means it could vertically integrate into on-demand delivery and directly compete with CardioNavix.
• Shared Medical Services: Provider of mobile diagnostic imaging solutions including PET/CT and SPECT to hospitals and practices nationwide. Directly comparable to CDL's mobile cardiac PET/CT trailer business model and target customer base.
• Lantheus Holdings: Radiopharmaceutical company producing cardiac PET tracers and SPECT agents (e.g., Pyrophosphate, Sestamibi) that overlap with CDL's isotope distribution business. Lantheus is a direct peer in radiopharmaceutical supply to cardiology customers.
• DMS Health Technologies: Mobile diagnostic imaging services provider offering PET/CT and other modalities to hospitals and clinics. Competes with CDL's mobile PET/CT trailer and managed services offering in overlapping US geographies.

Emerging players

• Positron Corporation: Specialized PET and PET/CT manufacturer focused on cardiac imaging. As an emerging OEM, Positron represents a potential alternative equipment source for CDL and a possible direct competitor in cardiac PET solutions.
• United Imaging Healthcare: PET/CT and SPECT manufacturer expanding aggressively in the US with competitive pricing. As an emerging OEM, it could pressure the Siemens/GE/Philips triad that underpins CDL's suite configurations and offer lower-cost equipment to CDL's customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CDL Nuclear Technologies